Its administration enhanced catalase activity and GSH levels while reducing hippocampal NF-κB and MMP-9 expression, highlighting the complex interplay between oxidative stress, inflammation, and cognitive impairment [37]. The gene discussed is NFKB1; the disease is Cognitive impairment.